Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Biglycan is a member of the small leucine-rich repeat proteo...

Class:IdSummation:9018147
_displayNameBiglycan is a member of the small leucine-rich repeat proteo...
_timestamp2017-09-06 10:04:55
created[InstanceEdit:9018149] Varusai, Thawfeek, 2017-08-30
modified[InstanceEdit:9018155] Varusai, Thawfeek, 2017-08-30
[InstanceEdit:9020462] Varusai, Thawfeek, 2017-09-06
textBiglycan is a member of the small leucine-rich repeat proteoglycan family (SLRPs) which also includes decorin, fibromodulin, lumican and asporin. All appear to be involved in collagen fibril formation and matrix assembly (Ameye & Young 2002). Mutations in COL1A1 result in structurally defective type 1 collagen. This abnormal type 1 collagen forms non-functional fibrils, which eventually leads to disorders. COL1A1 mutations may lead to disorders such as osteogenesis imperfecta. Mutations in only one COL1A1 allele may cause a mild disease because of reduced normal type 1 collagen. Severe and lethal diseases occur when there are dominant negative mutations in COL1A1 producing structurally defective type 1 collagen. Most common mutations are glycine residue substitutions by larger amino acids, which affect the formation of collagen triple helix (Dalgleish R 1997, Gajko-Galicka et al. 2002).
(summation)[Reaction:9018150] BGN binds COL1A1-defective collagen types I, VI, (IX) [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Biglycan is a member of the small leucine-rich repeat proteo... (9018147)